Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 33 of the 33 references it cites were found in a registry or an index.

Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium

Open access

Abstract

OBJECTIVE: To determine changes in the incidence of dementia between 1988 and 2015. METHODS: This analysis was performed in aggregated data from individuals >65 years of age in 7 population-based cohort studies in the United States and Europe from the Alzheimer Cohort Consortium. First, we calculated age- and sex-specific incidence rates for all-cause dementia, and then defined nonoverlapping 5-year epochs within each study to determine trends in incidence. Estimates of change per 10-year interval were pooled and results are presented combined and stratified by sex. RESULTS: Of 49,202 individuals, 4,253 (8.6%) developed dementia. The incidence rate of dementia increased with age, similarly for women and men, ranging from about 4 per 1,000 person-years in individuals aged 65-69 years to 65 per 1,000 person-years for those aged 85-89 years. The incidence rate of dementia declined by 13% per calendar decade (95% confidence interval [CI], 7%-19%), consistently across studies, and somewhat more pronouncedly in men than in women (24% [95% CI 14%-32%] vs 8% [0%-15%]). CONCLUSION: The incidence rate of dementia in Europe and North America has declined by 13% per decade over the past 25 years, consistently across studies. Incidence is similar for men and women, although declines were somewhat more profound in men. These observations call for sustained efforts to finding the causes for this decline, as well as determining their validity in geographically and ethnically diverse populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000010022

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Incidence rates of dementia, stratified by cohort and age group AGES–Reykjavik Study = Age, Gene/Environment Susceptibility–Reykjavik Study; CFAS = Cognitive Function and Ageing Studies; FHS = Framingham Heart Study; PAQUID = Personnes Agées QUID.
Figure 1 Incidence rates of dementia, stratified by cohort and age group AGES–Reykjavik Study = Age, Gene/Environment Susceptibility–Reykjavik Study; CFAS = Cognitive Function and Ageing Studies; FHS = Framingham Heart Study; PAQUID = Personnes Agées QUID.CC BY-NC-ND · PubMed Central
Figure 2 Incidence rates of dementia by age group, comparing men vs women
Figure 2 Incidence rates of dementia by age group, comparing men vs womenCC BY-NC-ND · PubMed Central
Figure 3 Trends in the incidence of dementia The forest plots represent the incidence trend for (A) all-cause dementia, (B) Alzheimer disease, (C) all-cause dementia in men, and (D) all-cause dementia in women, expressed as a hazard ratio (HR) per 10-year advance in calendar time. This HR was calculated to compare temporal trends across studies, and can be interpreted as a change in the 5-year hazard per decade advance in calendar time. 3C = Three-City Study; CFAS = Cognitive Function and Ageing Studies; CI = confidence interval; FHS = Framingham Heart Study; RS = Rotterdam Study.
Figure 3 Trends in the incidence of dementia The forest plots represent the incidence trend for (A) all-cause dementia, (B) Alzheimer disease, (C) all-cause dementia in men, and (D) all-cause dementia in women, expressed as a hazard ratio (HR) per 10-year advance in calendar time. This HR was calculated to compare temporal trends across studies, and can be interpreted as a change in the 5-year hazard per decade advance in calendar time. 3C = Three-City Study; CFAS = Cognitive Function and Ageing Studies; CI = confidence interval; FHS = Framingham Heart Study; RS = Rotterdam Study.CC BY-NC-ND · PubMed Central
Figure 4 Projected incidence of dementia in millions Projected yearly incidence of dementia on the basis of current rates (solid lines) and projected incidence of dementia assuming continuation of a decreasing trend (dashed lines). Current rates are based on estimates from the 2012 World Alzheimer Report, which at the time estimated that 682 million new cases would occur over the 2010 to 2050 period.
Figure 4 Projected incidence of dementia in millions Projected yearly incidence of dementia on the basis of current rates (solid lines) and projected incidence of dementia assuming continuation of a decreasing trend (dashed lines). Current rates are based on estimates from the 2012 World Alzheimer Report, which at the time estimated that 682 million new cases would occur over the 2010 to 2050 period.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 3

  1. Alzheimer’s Disease International. Policy Brief for G8 Heads of Government: The Global Impact of Dementia 2013–2050 [online]. Available at: alz.co.uk/research/G8-policy-brief. Accessed May 20, 2019.
  2. WHO. First WHO Ministerial Conference on Global Action Against Dementia [Internet]. Available at: hoint/mental_health/neurology/dementia/ministerial_conference_2015_report/en/(2015). Accessed February 25, 2018.
  3. Alzheimer's Disease International. World Alzheimer Report 2015 [Internet]. Available at: alzcouk/research/world-report-2015. Accessed February 26, 2018.

Cited by

See all 525

Metadata

Authors
Wolters, F. J., Chibnik, L. B., Waziry, R., Anderson, R., Berr, C., Beiser, A., Bis, J. C., Blacker, D., Bos, D., Brayne, C., Dartigues, J.-F., Darweesh, S. K. L., Davis-Plourde, K. L., de Wolf, F., Debette, S., Dufouil, C., Fornage, M., Goudsmit, J., Grasset, L., Gudnason, V., Hadjichrysanthou, C., Helmer, C., Ikram, M. A., Ikram, M. K., Joas, E., Kern, S., Kuller, L. H., Launer, L., Lopez, O. L., Matthews, F. E., McRae-McKee, K., Meirelles, O., Mosley, T. H., Pase, M. P., Psaty, B. M., Satizabal, C. L., Seshadri, S., Skoog, I., Stephan, B. C. M., Wetterberg, H., Wong, M. M., Zettergren, A., & Hofman, A.
Affiliations
  • Harvard University (US)
  • Boston University (US)
  • From the Department of Epidemiology (F.J.W., L.B.C., R.W., D. Blacker, D. Bos, J.G., A.H.), Harvard T.H. Chan School of Public Health, Boston, MA; Departments of Epidemiology (F.J.W., D. Bos, S.K.L.D., M.A.I., M.K.I., A.H.), Radiology and Nuclear Medicine (D. Bos), and Neurology (M.K.I.), Erasmus MC, Rotterdam, the Netherlands; Department of Neurology (L.B.C.), Massachusetts General Hospital, Boston; Department of Infectious Disease Epidemiology (R.A., F.d.W., C. Hadjichrysanthou, K.M.-M., M.M.W.),...
Venue
Neurology
Published
2020-08-04
Volume
95
Issue
5
Pages
e519-e531
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3082444018
Cited by
489
References
33
Citations by year
2026: 57 · 2025: 108 · 2024: 90 · 2023: 85 · 2022: 85 · 2021: 54 · 2020: 9
FWCI
42.49
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Neurology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
  • HAL (submittedVersion, cc-by-nc-nd)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by-nc-nd)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
  • Opin vísindi (Opin vísindi) (submittedVersion, cc-by-nc-sa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Opin vísindi (Opin vísindi) (submittedVersion, other-oa)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by-nc-nd)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
Funders
  • Alzheimer's Association (IIRG-09-131338, AG033040, NS017950, AG033193, 2008-1229, ZEN‐01‐3151)
  • GlaxoSmithKline
  • Sanofi
  • Yale University
  • Västra Götalandsregionen
  • Stiftelsen för Gamla Tjänarinnor
  • National Institute for Health and Care Research (G9901400)
  • European Commission (FP7 ICT, 601055, HORIZON2020, ICT-2011, 2007e2013, FP7/2007e2013, FP7‐ICT‐2011, 667375)
  • Agence Nationale de la Recherche (06‐PNRA‐005, ANR‐06‐PNRA‐005, COGINUT ANR-06-PNRA-005, ANR-06-PNRA-0005, 2009-2012, ANR-07-LVIE-0003)
  • Institut National de la Santé et de la Recherche Médicale (2009-2012)
  • ZonMw
  • Erasmus Universiteit Rotterdam
  • Forskningsrådet för Arbetsliv och Socialvetenskap (2003-0234, 2006-0596, ZEN-01-3151, 2010-0870, 2006-0020, 2001-2646, 2008-1229, 2004-0150, 2013-2496, 2013-2300, 2008-1111, 2012-1138, 2004-0145)
  • VSNU Vereniging van Universiteiten
  • Fondation pour la Recherche Médicale
  • Ministerie van Onderwijs, Cultuur en Wetenschap
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Hjärnfonden
  • Vetenskapsrådet (2013–8,717, 2010-0870, 2012‐1138, 2013-2300, 2013‐2496, 2015-02830, 2015-02830, 2013-8717, 2012–5,041)
  • Fondation de France
  • Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
  • Université de Bordeaux
  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2013-8717, 2008-1111, 2003‐0234, 2013‐2496, 2004‐0150, 2013‐2300, 2008‐1229, 2006-0596, 2006‐0020, 2004-0145, 2010-0870, 2013-1202, 2012‐1138, 2001‐2646, ZEN-01-3151)
  • Mutuelle Générale de l'Education Nationale
  • Hjartavernd (HHSN271201200022C, N01-AG-1-2100)
  • Ipsen
  • Janssen Prevention Center
  • National Institutes of Health (n01ag12100-57-0-2, n01hc25195-41-0-1)
  • Novartis Pharma
  • Medical Research Council (G06010220, G9901400, MR/R015600/1)
  • National Institute on Aging (AG-008122, AG049505, U01AG049505, N01-AG12100, AG054076, N01-HC-25195, U01AG052409, AG052409, R01AG054076, R01AG049607, AG033193, NS017950, R01AG033040, AG058589, AG 033040, AG059421, R01AG033193, RF1AG059421, R01AG008122, HHSN271201200022C, P30AG062421, P30AG066546)
  • National Heart, Lung, and Blood Institute (HC25195, HL-105756, N01‐HC25195, HHSN268201500001I, HHSN268201500001C, U01HL130114, N01-HC, N01-HC-25195 and HHSN268201500001I, NS100605, AG033040, NS017950, AG033193)
  • National Institute on Drug Abuse (HHSN271201200022C)
  • National Eye Institute
  • National Institute on Deafness and Other Communication Disorders (HHSN268201500001I)
  • National Institute of Neurological Disorders and Stroke (UH2NS100605, UH3NS100605, R01NS017950)
  • Janssen Pharmaceuticals
  • H2020 European Research Council (678543)
  • FP7 Information and Communication Technologies
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
Keywords
dementia incidence, temporal trends, Alzheimer's disease, older adults, sex differences, age-specific incidence, population-based cohort, Europe, United States
MeSH terms
Aged, Aged, 80 and over, Dementia, Europe, Female, Humans, Male, United States, Cohort Studies, Incidence, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. https://app.cochat.ai/papers/10.1212/wnl.0000000000010022
The paper
Wolters, F. J., Chibnik, L. B., Waziry, R., Anderson, R., Berr, C., Beiser, A., Bis, J. C., Blacker, D., Bos, D., Brayne, C., Dartigues, J.-F., Darweesh, S. K. L., Davis-Plourde, K. L., de Wolf, F., Debette, S., Dufouil, C., Fornage, M., Goudsmit, J., Grasset, L., . . . Hofman, A. (2020). Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology. https://doi.org/10.1212/wnl.0000000000010022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.